Newron Pharmaceuticals (NWPHF) Short Interest Ratio & Short Volume → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free NWPHF Stock Alerts $11.40 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Newron Pharmaceuticals Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume44,600 sharesChange Vs. Previous Month-99.78%Dollar Volume Sold Short$852.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares17,850,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume1,525 sharesToday's Volume Vs. Average0% Short Selling Newron Pharmaceuticals ? Sign up to receive the latest short interest report for Newron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNWPHF Short Interest Over TimeNWPHF Days to Cover Over TimeNWPHF Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Newron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024100 shares $852.00 -99.8%N/A0 $8.52 3/31/202444,600 shares $379,992.00 +50.7%N/A0 $8.52 3/15/202429,600 shares $252,192.00 +60.0%N/A0 $8.52 2/29/202418,500 shares $157,620.00 +537.9%N/A0 $8.52 2/15/20242,900 shares $24,708.00 +480.0%N/A0 $8.52 1/15/20242,700 shares $21,330.00 -89.2%N/A6.8 $7.90 Get the Latest News and Ratings for NWPHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Newron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202324,900 shares $129,978.00 +66.0%N/A101.9 $5.22 12/15/202315,000 shares $93,300.00 -35.3%N/A0 $6.22 11/30/202323,200 shares $144,304.00 -27.0%N/A0 $6.22 11/15/202331,800 shares $197,796.00 +27.2%N/A0 $6.22 10/31/202325,000 shares $155,500.00 +24,900.0%N/A0 $6.22 10/15/2023100 shares $622.00 -99.5%N/A0 $6.22 9/30/202318,600 shares $115,692.00 -22.5%N/A0 $6.22 9/15/202324,000 shares $149,280.00 +566.7%N/A0 $6.22 8/31/20233,600 shares $22,392.00 -63.3%N/A35 $6.22 8/15/20239,800 shares $19,796.00 -10.9%N/A0 $2.02 7/31/202311,000 shares $22,220.00 +10,900.0%N/A0 $2.02 7/15/2023100 shares $202.00 No ChangeN/A1 $2.02 6/30/2023100 shares $202.00 No ChangeN/A0 $2.02 6/15/2023100 shares $202.00 No ChangeN/A0 $2.02 5/31/2023100 shares $202.00 -97.1%N/A0 $2.02 5/15/20233,500 shares $7,070.00 +3,400.0%N/A0 $2.02 4/30/2023100 shares $202.00 -99.5%N/A0 $2.02 4/15/202319,200 shares $38,784.00 -70.4%N/A0 $2.02 3/31/202364,900 shares $131,098.00 -35.5%N/A0 $2.02 3/15/2023100,600 shares $203,212.00 +21.5%N/A0 $2.02 2/28/202382,800 shares $167,256.00 +82,700.0%N/A828 $2.02 2/15/2023100 shares $202.00 -91.7%N/A0 $2.02 1/31/20231,200 shares $2,424.00 +1,100.0%N/A0 $2.02 1/15/2023100 shares $202.00 No ChangeN/A1 $2.02 12/15/2022100 shares $210.00 No ChangeN/A0 $2.10 11/30/2022100 shares $210.00 No ChangeN/A0 $2.10 11/15/2022100 shares $210.00 No ChangeN/A0 $2.10 10/31/2022100 shares $210.00 No ChangeN/A0 $2.10 10/15/2022100 shares $210.00 No ChangeN/A0 $2.10 9/30/2022100 shares $210.00 No ChangeN/A0 $2.10 9/15/2022100 shares $210.00 No ChangeN/A0 $2.10 8/31/2022100 shares $210.00 No ChangeN/A0 $2.10 8/15/2022100 shares $210.00 No ChangeN/A0 $2.10 7/31/2022100 shares $210.00 No ChangeN/A0 $2.10The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> NWPHF Short Interest - Frequently Asked Questions What is Newron Pharmaceuticals' current short interest? Short interest is the volume of Newron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 100 shares of NWPHF short. Learn More on Newron Pharmaceuticals' current short interest. Is Newron Pharmaceuticals' short interest increasing or decreasing? Newron Pharmaceuticals saw a decrease in short interest in April. As of April 15th, there was short interest totaling 100 shares, a decrease of 99.8% from the previous total of 44,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Newron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Newron Pharmaceuticals: Regulus Therapeutics Inc. (10.92%), CervoMed Inc. (0.71%), Seres Therapeutics, Inc. (11.67%), ProQR Therapeutics (0.47%), Skye Bioscience, Inc. (0.29%), Syros Pharmaceuticals, Inc. (10.10%), Greenwich LifeSciences, Inc. (3.17%), Cybin Inc. (3.64%), Gossamer Bio, Inc. (4.91%), scPharmaceuticals Inc. (13.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Newron Pharmaceuticals stock? Short selling NWPHF is an investing strategy that aims to generate trading profit from Newron Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Newron Pharmaceuticals? A short squeeze for Newron Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NWPHF, which in turn drives the price of the stock up even further. How often is Newron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWPHF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Regulus Therapeutics Short Squeeze CervoMed Short Squeeze Seres Therapeutics Short Squeeze ProQR Therapeutics Short Squeeze Skye Bioscience Short Squeeze Syros Pharmaceuticals Short Squeeze Greenwich LifeSciences Short Squeeze Cybin Short Squeeze Gossamer Bio Short Squeeze scPharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWPHF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits